79. Mondello P, Hatti S, Vitale MG, et al. Anti-HCV antibodies in househoId contacts of patienis with cirrhosis of Ijver-preIiminary results. Infection 1991 ;20:51-52
80. Tanaka E, Kiyosawa K, Takunaga K, et al. PrevaIence of antibody to hepatitis C virus in Japanese schoolchildren: a comparison with adult blood donors. Am J Trop Med Hyg 1992;46:460-464
81. Hafta A, Çolakoğlu S, Akkız H, ve ark. Çukurova bölgesinde çeşitli risk gruplarında anti HCV seroprevalansı. ViraI Hepatit Derg. 1996; 1: 46-49
82. Bronowicki JP. Patient to transmission of hepatitis C during coIonoscopy. N Eng J Med 1997;337
83. Branch AD, Seef LB. Foreword. Hepatitis C: State of the art at the millenium. Semin Liver Dis 2000;20:iii
84. AJberti A, ChemeIlo L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999;31: 17-24
85. Ökten A, Acar A, Çakaloğlu Y, ve ark. Karaciğer siramııun etiyolojisi (1052 vaka analizi) TKI Gastroenterohepatoloji 1995;6:45-48.
86. Dienstag JL. Non-A, non-B hepfltitis. 1. Recognition, epidemiology and clinical features. Gastroenterology 1983;85;439-462
87. Alter HJ, Purcell RH, Holland PV Popper H. Transmissiable agent in nonA, non-B hepatitis. Lancet 1978;85:439-463
88. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C. N Eng J Med 1995;332:1463-1466
89. Kiyosawa K, Sadeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B heparitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-675
90. Alter JH, Seef LB. Recovery, persistence, and sequelae in hepatitis C virus infection: A prospective on long-term outcome. Seminars in Liver disease 2000;20:17-35
61



69. SAYFAYA BENZER SAYFALAR

tabs_sener_yagiz_191898 - Sayfa
...


69. SAYFA ICERIGI

79. Mondello P, Hatti S, Vitale MG, et al. Anti-HCV antibodies in househoId contacts of patienis with cirrhosis of Ijver-preIiminary results. Infection 1991 ;20:51-52
80. Tanaka E, Kiyosawa K, Takunaga K, et al. PrevaIence of antibody to hepatitis C virus in Japanese schoolchildren: a comparison with adult blood donors. Am J Trop Med Hyg 1992;46:460-464
81. Hafta A, Çolakoğlu S, Akkız H, ve ark. Çukurova bölgesinde çeşitli risk gruplarında anti HCV seroprevalansı. ViraI Hepatit Derg. 1996; 1: 46-49
82. Bronowicki JP. Patient to transmission of hepatitis C during coIonoscopy. N Eng J Med 1997;337
83. Branch AD, Seef LB. Foreword. Hepatitis C: State of the art at the millenium. Semin Liver Dis 2000;20:iii
84. AJberti A, ChemeIlo L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999;31: 17-24
85. Ökten A, Acar A, Çakaloğlu Y, ve ark. Karaciğer siramııun etiyolojisi (1052 vaka analizi) TKI Gastroenterohepatoloji 1995;6:45-48.
86. Dienstag JL. Non-A, non-B hepfltitis. 1. Recognition, epidemiology and clinical features. Gastroenterology 1983;85;439-462
87. Alter HJ, Purcell RH, Holland PV Popper H. Transmissiable agent in nonA, non-B hepatitis. Lancet 1978;85:439-463
88. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C. N Eng J Med 1995;332:1463-1466
89. Kiyosawa K, Sadeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B heparitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-675
90. Alter JH, Seef LB. Recovery, persistence, and sequelae in hepatitis C virus infection: A prospective on long-term outcome. Seminars in Liver disease 2000;20:17-35
61

İlgili Kaynaklar







single.php